4.5 Article

Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8)

Journal

ACS MEDICINAL CHEMISTRY LETTERS
Volume 13, Issue 5, Pages 812-818

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.2c00049

Keywords

Toll-like receptor; TLR; pattern recognition receptor; autoimmunity; innate immunity; lupus

Ask authors/readers for more resources

Toll-like receptors are crucial for activation of the innate immune system. Aberrant activation of TLR7 and TLR8 can lead to autoimmune disorders, and inhibition of their signaling holds promise for disease treatment. A study identified potent dual inhibitors of TLR7 and TLR8, which selectively targeted these receptors and showed promising in vitro and in vivo results.
The toll-like receptors (TLRs) play key roles in activation of the innate immune system. Aberrant activation of TLR7 and TLR8 pathways can occur in the context of autoimmune disorders due to the elevated presence and recognition of self-RNA as activating ligands. Control of this unintended activation via inhibition of TLR7/8 signaling holds promise for the treatment of diseases such as psoriasis, arthritis, and lupus. Optimization of a 2-pyridinylindole series of compounds led to the identification of potent dual inhibitors of TLR7 and TLR8, which demonstrated good selectivity against TLR9 and other family members. The in vitro characterization and in vivo evaluation in rodent pharmacokinetic/pharmacodynamic and efficacy studies of BMS-905 is detailed, along with structural information obtained through X-ray cocrystallographic studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available